From: PELI1: key players in the oncogenic characteristics of pancreatic Cancer
Clinicopathological features | PELI1 Expression Level | X2 | P | ||
---|---|---|---|---|---|
Low | High | ||||
Total cases | 36 | 54 | |||
Age | < 60 | 20 | 27 | 0.267 | 0.605 |
≥ 60 | 16 | 27 | |||
Gender | Male | 24 | 29 | 1.499 | 0.221 |
Female | 12 | 25 | |||
Tumor size | < 5 | 30 | 30 | 7.50 | 0.006 |
≥ 5 | 6 | 24 | |||
pTNM stage | I-II | 34 | 19 | 31.331 | < 0.001 |
III-IV | 2 | 35 | |||
T stage | I-II | 26 | 19 | 11.852 | 0.001 |
III-IV | 10 | 35 | |||
Lymphatic node metastasis | N0 | 20 | 13 | 9.219 | 0.002 |
N1 | 16 | 41 | |||
Distantly metastasized | M0 | 34 | 32 | 13.674 | < 0.001 |
M1 | 2 | 22 | |||
Number of foci | Single | 29 | 40 | 0.507 | 0.476 |
Multiple | 7 | 14 | |||
Vascular invasion | No | 26 | 26 | 5.132 | 0.023 |
Yes | 10 | 28 | |||
Nerve violation | No | 12 | 19 | 0.033 | 0.856 |
Yes | 24 | 35 | |||
Degree of differentiation | Low | 8 | 27 | 8.42 | 0.015 |
Middle | 23 | 25 | |||
High | 5 | 2 | |||
CEA | 2.375(1.775 ~ 4.305) | 3.575(2.375 ~ 2.288) | 2.949 | 0.085 | |
CA19–9 | 85.6 (24.68 ~ 284.25) | 295.95(72.79 ~ 580.70) | 6.54 | 0.011 |